<code id='764481D004'></code><style id='764481D004'></style>
    • <acronym id='764481D004'></acronym>
      <center id='764481D004'><center id='764481D004'><tfoot id='764481D004'></tfoot></center><abbr id='764481D004'><dir id='764481D004'><tfoot id='764481D004'></tfoot><noframes id='764481D004'>

    • <optgroup id='764481D004'><strike id='764481D004'><sup id='764481D004'></sup></strike><code id='764481D004'></code></optgroup>
        1. <b id='764481D004'><label id='764481D004'><select id='764481D004'><dt id='764481D004'><span id='764481D004'></span></dt></select></label></b><u id='764481D004'></u>
          <i id='764481D004'><strike id='764481D004'><tt id='764481D004'><pre id='764481D004'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:17398

          What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week. Then, we dive into the fascinating world of fetal genome surgery, as STAT’s Megan Molteni joins us to explain the work of a scientist named Tippi MacKenzie.

          advertisement

          For more on what we cover, here’s the news on Gonzalez; here’s the story on MacKenzie; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Patients, doctors press FTC to beef up hospital merger scrutiny
          Patients, doctors press FTC to beef up hospital merger scrutiny

          TheFTCandDOJgotafloodofcommentsurgingthemtoadopttheirproposedmergerrules,includingmanyfromregularpeo

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          PBMs drew scrutiny in House hearing — and so did pharma

          Rep.JamesComer,chairoftheHouseOversightCommitteeKevinDietsch/GettyImagesWASHINGTON—Congresswantstore